{"id":54302,"date":"2023-02-28T11:06:30","date_gmt":"2023-02-28T10:06:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/"},"modified":"2023-02-28T11:06:30","modified_gmt":"2023-02-28T10:06:30","slug":"global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","title":{"rendered":"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644545\/global-senile-dementia-clinical-trial-pipeline?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f3wf3k&amp;utm_campaign=1824570+-+Global+Senile+Dementia+Clinical+Trial+Pipeline+Highlights+2022+Report&amp;utm_exec=jamu273prd-senile?w=4\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Senile Dementia Clinical Trial Pipeline Highlights &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230228005822\/en\/1725158\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230228005822\/en\/1725158\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report provides the most up-to-date information on key pipeline products within the global Senile Dementia market. It covers emerging therapies for Senile Dementia in active clinical development stages including early and late stage clinical trials.\n<\/p>\n<p>\nThe pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.\n<\/p>\n<p>\n<strong>Clinical Trial Stages:<\/strong>\n<\/p>\n<p>\nThe report provides Senile Dementia pipeline products by clinical trial stages including both early and late stage development &#8211; phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.\n<\/p>\n<p>\n<strong>Drug Mechanism Classes:<\/strong>\n<\/p>\n<p>\nThe report provides Senile Dementia pipeline products by their dominant mechanism of action\/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.\n<\/p>\n<p>\n<strong>Company:<\/strong>\n<\/p>\n<p>\nThe report provides Senile Dementia pipeline products by the company.\n<\/p>\n<p>\n<strong>Short-term Launch Highlights:<\/strong>\n<\/p>\n<p>\nFind out which Senile Dementia pipeline products will be launched in the US and Ex-US till 2025.\n<\/p>\n<p>\n<strong>Summary:<\/strong>\n<\/p>\n<ul>\n<li>\nSenile Dementia phase 3 clinical trial pipeline products\n<\/li>\n<li>\nSenile Dementia phase 2 clinical trial pipeline products\n<\/li>\n<li>\nSenile Dementia phase 1 clinical trial pipeline products\n<\/li>\n<li>\nSenile Dementia preclinical research pipeline products\n<\/li>\n<li>\nSenile Dementia discovery stage pipeline products\n<\/li>\n<li>\nSenile Dementia pipeline products short-term launch highlights\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644545\/global-senile-dementia-clinical-trial-pipeline?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f3wf3k&amp;utm_campaign=1824570+-+Global+Senile+Dementia+Clinical+Trial+Pipeline+Highlights+2022+Report&amp;utm_exec=jamu273prd-senile?w=4\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/pnq2ui-senile?w=4<\/a>\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#112;&#114;&#101;&#115;&#115;&#64;res&#x65;&#x61;&#x72;&#x63;&#x68;&#x61;&#x6e;&#x64;&#109;&#97;&#114;&#107;&#101;ts&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#101;&#x73;&#x73;&#x40;&#x72;e&#115;&#101;&#97;&#x72;&#x63;&#x68;an&#100;&#109;&#x61;&#x72;&#x6b;et&#115;&#46;&#x63;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Senile Dementia Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Senile Dementia market. It covers emerging therapies for Senile Dementia in active clinical development stages including early and late stage clinical trials. The &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54302","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Senile Dementia Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Senile Dementia market. It covers emerging therapies for Senile Dementia in active clinical development stages including early and late stage clinical trials. The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-28T10:06:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230228005822\/en\/1725158\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-02-28T10:06:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\"},\"wordCount\":334,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228005822\\\/en\\\/1725158\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\",\"name\":\"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228005822\\\/en\\\/1725158\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-02-28T10:06:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228005822\\\/en\\\/1725158\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228005822\\\/en\\\/1725158\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Senile Dementia Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Senile Dementia market. It covers emerging therapies for Senile Dementia in active clinical development stages including early and late stage clinical trials. The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-28T10:06:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230228005822\/en\/1725158\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report &#8211; ResearchAndMarkets.com","datePublished":"2023-02-28T10:06:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/"},"wordCount":334,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230228005822\/en\/1725158\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","name":"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230228005822\/en\/1725158\/21\/logo.jpg","datePublished":"2023-02-28T10:06:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230228005822\/en\/1725158\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230228005822\/en\/1725158\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-senile-dementia-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Senile Dementia Clinical Trial Pipeline Highlights 2022 Report &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54302"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54302\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}